These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 26898096)

  • 1. [Interrelationship of Matrix Metalloproteinase-9 and Its Tissue Inhibitor-1 and Blood Lipid Profile of Patients With Carotid Atherosclerosis].
    Usmanova ZA; Rosykhodzhaeva GA
    Kardiologiia; 2015; 55(9):57-8. PubMed ID: 26898096
    [No Abstract]   [Full Text] [Related]  

  • 2. Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in blood as markers for early atherosclerosis in subjects with chronic periodontitis.
    Söder PO; Meurman JH; Jogestrand T; Nowak J; Söder B
    J Periodontal Res; 2009 Aug; 44(4):452-8. PubMed ID: 18973519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [THE ANALYSIS OF ASSOCIATION OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 WITH LEVEL OF ZINC IN DIFFERENT BIO SUBSTRATES IN PATIENTS WITH CAROTID STENOSIS].
    Usmanova ZA; Aripov AN
    Klin Lab Diagn; 2015 Oct; 60(10):26-8. PubMed ID: 26841668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum matrix metalloproteinase-3 and tissue inhibitor of metalloproteinases-1 as potential markers of carotid atherosclerosis in infraclinical hyperlipidemia.
    Beaudeux JL; Giral P; Bruckert E; Bernard M; Foglietti MJ; Chapman MJ
    Atherosclerosis; 2003 Jul; 169(1):139-46. PubMed ID: 12860260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and -2 in type 2 diabetes: effect of 1 year's cardiovascular risk reduction therapy.
    Tayebjee MH; Lim HS; MacFadyen RJ; Lip GY
    Diabetes Care; 2004 Aug; 27(8):2049-51. PubMed ID: 15277439
    [No Abstract]   [Full Text] [Related]  

  • 6. Oxidized low-density lipoprotein, matrix-metalloproteinase-8 and carotid atherosclerosis in spinal cord injured subjects.
    Paim LR; Schreiber R; Matos-Souza JR; Silva AA; Campos LF; Azevedo ER; Alonso K; de Rossi G; Etchebehere M; Gorla JI; Cliquet A; Nadruz W
    Atherosclerosis; 2013 Dec; 231(2):341-5. PubMed ID: 24267248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using plasma matrix metalloproteinase-9 and monocyte chemoattractant protein-1 to predict future cardiovascular events in subjects with carotid atherosclerosis.
    Ma Y; Yabluchanskiy A; Hall ME; Lindsey ML
    Atherosclerosis; 2014 Jan; 232(1):231-3. PubMed ID: 24401244
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.
    Romero JR; Vasan RS; Beiser AS; Polak JF; Benjamin EJ; Wolf PA; Seshadri S
    J Stroke Cerebrovasc Dis; 2008; 17(6):412-7. PubMed ID: 18984437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misuse of serum matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 as a biomarker in multiple sclerosis.
    Gerlach RF; Tanus-Santos JE
    Mult Scler; 2006 Feb; 12(1):120. PubMed ID: 16459731
    [No Abstract]   [Full Text] [Related]  

  • 10. Matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and tumour necrosis factor alpha release during cardiopulmonary bypass.
    Galley HF; Macaulay GD; Webster NR
    Anaesthesia; 2002 Jul; 57(7):659-62. PubMed ID: 12059824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFFECT OF RELATIVE GENE EXPRESSION ON PLAQUE VULNERABILITY IN PATIENTS WITH STABLE ANGINA AND PATIENTS WITH ACUTE CORONARY SYNDROME.
    Chen N; Zhang JY; Yang SZ; Li YD
    J Biol Regul Homeost Agents; 2015; 29(2):437-41. PubMed ID: 26122234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in acute pancreatitis.
    Wereszczynska-Siemiatkowska U; Siemiatkowski A; Swidnicka-Siergiejko A; Mroczko B; Dabrowski A
    Z Gastroenterol; 2015 Mar; 53(3):199-204. PubMed ID: 25775169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2, -9, and tissue inhibitor of metalloproteinase-1 in patients with hypertension.
    Derosa G; D'Angelo A; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo S; Montagna L; Gravina A; Ferrari I; Galli S; Paniga S; Tinelli C; Cicero AF
    Endothelium; 2006; 13(3):227-31. PubMed ID: 16840178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein.
    Alqahtani MF; Smith CM; Weiss SL; Dawson S; Ralay Ranaivo H; Wainwright MS
    PLoS One; 2016; 11(4):e0153645. PubMed ID: 27089280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-9 Levels and IMT of Carotid Arteries are Elevated in Obese Children and Adolescents Compared to Non-Obese.
    Andrade C; Bosco A; Sandrim V; Silva F
    Arq Bras Cardiol; 2017 Mar; 108(3):198-203. PubMed ID: 28443954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Levels of Soluble Cluster of Differentiation 40 Ligand, Matrix Metalloproteinase 9, and Matrix Metalloproteinase 2 Are Associated with Carotid Plaque Vulnerability in Patients with Ischemic Cerebrovascular Disease.
    Han Y; Mao X; Wang L; Liu J; Wang D; Cheng H; Miao G
    World Neurosurg; 2017 Sep; 105():709-713. PubMed ID: 28642174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease.
    Coll B; Rodríguez JA; Craver L; Orbe J; Martínez-Alonso M; Ortiz A; Díez J; Beloqui O; Borras M; Valdivielso JM; Fernández E; Páramo JA
    Kidney Int; 2010 Dec; 78(12):1275-80. PubMed ID: 20844474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Atherosclerosis; 2007 Jan; 190(1):199-204. PubMed ID: 16510149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.